RxDoctor Payments DataLook up a doctor →

Sarah Jackson, MD

Dermatology · New Orleans, LANPI 1790724326

Payments from drug & device makers

$1,734,965in general payments, 2019–2025

Across 2,047 payments — averaging $847.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$730K
  • Taro Pharmaceuticals USA, Inc.$373K
  • Sanofi Pasteur Inc.$161K
  • Endo Pharmaceuticals Inc.$140K
  • AbbVie$133K
  • Dermavant Sciences, Inc.$61K
  • plus $135K from 39 others
$685in research payments, 2019–2025

Across 4 payments — averaging $171.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$685

What the payments were for

  • Consulting fees$43,81526%
  • Speaking & faculty fees$83,35750%
  • Travel & lodging$20,64812%
  • Food & beverage$19,13211%
  • Education$3720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,734,965 in reported general payments places this provider in the 95th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana

Medicare billing

Part B allowed, 2024
$99,793
Medicare patients
320
Services billed
2,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole83$1,630
Triamcinolone Acetonide136$1,055
Clobetasol Propionate25$967
Metronidazole16$672
Mupirocin84$638
Fluorouracil11$568
Doxycycline Hyclate16$522
Nystatin37$452
Finasteride40$258
ValacyclovirValacyclovir Hcl20$252
Minoxidil12$228
Spironolactone11$62

Paid to pharmacies, not to this prescriber.

Other dermatology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →